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From January 1960 to June 1995, 185 patients underwent reoperation 
without esophageal resection for symptoms of recurrent gastroesophageal 
reflux disease. There were 102 men and 83 women. Median age was 58 years 
(range 20 to 84 years). A single previous antireflux operation had been 
performed in 147 patients, two in 33, and three in 5. The median interval 
between the reoperation and the previous operation was 36 months (range 
1 to 291 months). Indications for reoperation were symptoms in 184 
patients and a large paraesophageal hernia in one patient. The surgical 
approach was by means of a thoracotomy in 133 patients (71.9%), laparot- 
omy in 27 (14.6%), and a thoracoabdominal incision in 25 (13.5%). A Nissen 
fundoplication was performed in 107 patients (57.8%), Belsey fundoplica- 
tion in 47 (25.4%), truncal vagotomy and antrectomy with Roux-en-Y 
reconstruction i  17 (9.2%), anatomic hernia repair in 12 (6.5%), and Hill 
gastropexy in 2 (1.1%). A Collis gastroplasty was added to the fundoplica- 
tion in 116 patients (62.7%), and a pyloroplasty was performed in 17 (9.2%). 
There was one operative death (0.5%). Complications occurred in 47 
patients (25.4%). Median postoperative hospitalization was 9 days (range 5 
to 58 days). Follow-up was complete in 156 patients (84.3%) and ranged 
from 3 to 283 months (median 44 months). Improvement occurred in 137 
patients (87.8%). Functional results were classified as excellent in 65 
patients (41.6%), good in 29 (18.6%), fair in 43 (27.6%), and poor in 19 
(12.2%). No single operative approach or procedure proved to be function- 
ally superior. We conclude that reoperation with esophageal preservation 
after a failed antireflux procedure will result in significant functional 
benefit and can be performed with low mortality and acceptable morbidity. 
The type of repair should be tailored to the individual patient. (J Thorac 
Cardiovasc Surg 1997;113:545-51) 
p rimary surgical treatment for gastroesophageal 
reflux disease (GERD) is associated with a long- 
term success rate of 80% to 90%, 1-3 whereas reop- 
erations are associated with a success rate varying 
from 42% to 94%. 4-13 Factors associated with failure 
and recurrence are not well known, and the oPtimal 
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surgical treatment of recurrences i debated. To 
evaluate long-term functional results, we retrospec- 
tively reviewed our experience in patients who un- 
derwent reoperation without esophageal resection 
for recurrent reflux or obstruction symptoms. 
Patients and methods 
From January 1960 to June 1995, 2079 patients under- 
went an antireflux procedure atthe Mayo Clinic. Of these, 
185 patients (8.9%) had reoperation without esophageal 
resection. The records of these 185 patients were analyzed 
for age, gender, symptoms, perative morbidity and mor- 
tality, and factors affecting late functional outcome. Data 
were acquired from questionnaires sent to patients and 
referring physicians and from visits to the outpatient 
clinic. Operative deaths included patients who died within 
the first 30 days after operation and those who died later 
but during the same hospitalization. Functional status was 
considered excellent if the patient was without symptoms 
and not receiving medication; status was considered good 
if the patients had mild symptoms without medication or 
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Table I. Complications 
Complications No. (%) 
Leak 12 (6.5) 
Atelect asis/pneumonia 9 (4.9) 
Arrhythmia 9 (4.9) 
Delayed gastric emptying 4 (2.1) 
Wound infection 3 (1.6) 
Splenic injury 2 (1.1) 
Acute gastric herniation 1 (0.5) 
Bleeding 1 (0.5) 
Other 6 (3.1) 
needed only one postoperative dilatation; it was fair if 
symptoms were controlled with medication or periodical 
dilatations; it was poor if the patient's condition was 
unimproved after surgery or warranted reoperation be- 
cause of a complication. 7 All hernias were classified 
according to the method of Skinner. TM 
Two-way contingency tables were used to determine 
which clinical factors were associated with the functional 
outcome. Tests for independence were carried out with an 
exact Wilcoxon test for ordered categoric variables.15 The 
relationship between the functional result and the clinical 
factors was analyzed further by fitting a logistic regression 
model] 6 In this case, the outcome variable was treated as 
binary, with the categories of excellent, good, fair, and 
poor. The risk of reoperation was estimated by computing 
Kaplan-Meier survival curves. 17 Estimates were computed 
for the overall patient sample, as well as for subgroups 
that were based on clinical risk factors. Patient groups 
exhibiting different levels of a particular isk factor were 
compared by means of the log-rank test] 8 The threshold 
for statistical significance for all tests was set at p = 0.05. 
Clinical findings. There were 102 men (55.1%) and 83 
women (44.9%). The median age at the time of reopera- 
tion was 58 years (range 20 to 84 years). One hundred 
forty-seven patients had one previous antireflux proce- 
dure, 33 had two, and 5 had three. Previous antireflux 
operations included 140 transabdominal Nissen fundopli- 
cations, 37 anatomic hernia repairs, 19 Belsey fundoplica- 
tions, 14 transthoracic Nissen fundoplications, 10 Hill 
gastropexy, 7 Angelchik prosthesis, and 1 unknown. Me- 
dian time between the most recent antireflux operation 
and reoperation at our institution was 36 months (range 1 
to 291 months). Thirty-eight patients had previous urgery 
for peptic ulcer disease. Of these, 26 had truncal vagotomy 
and pyloroplasty, 5 had truncal vagotomy and gastrojeju- 
nostomy, 4 had truncal vagotomy and antrectomy, and 3 
had highly selective vagotomy. Indications for surgery 
were recurrent reflux symptoms in 134 patients (72.4%), 
esophageal obstruction in 50 (27.0%), and a large para- 
esophageal hernia in 1 (0.06%). Duration of symptoms 
ranged from 1 to 40 years (median 2 years). Pyrosis was 
present in 135 patients (80.0%), dysphagia in 124 (67.0%), 
regurgitation in 94 (50.8%), pain in 93 (50.3%), and 
previous episodes of aspiration in 35 (18.9%). Esophageal 
dilatation had been performed at least once in 56 patients 
(30.3%) before reoperation. Weight loss was observed in 
15 patients (median 11.4 kg, range 2.3 to 34.1 kg). Barium 
roentgenographic examination of the esophagus was per- 
formed in 179 patients (96.8%), esophagoscopy in 174 
(94.1%), esophageal manometry in 152 (82.2%), and a pH 
study in 42 (22.7%). Barium swallow analysis showed a 
hiatal hernia in 143 patients (79.9%) and a stricture in 40 
(22.3%). Esophagitis or a stricture was present at esopha- 
goscopy in 130 patients (74.7%), and Barrett's disease was 
documented histologically in 29 (16.7%). Low amplitude 
peristalsis of the body of the esophagus was shown on 
manometry in 38 patients (25%). The lower esophageal 
sphincter was hypotensive in 95 patients (62.5%) and 
hypertensive in 6 (3.9%). Thirty-three patients (78.6%) 
had a positive pH study. After preoperative valuation, 
169 patients (91.4%) were considered to have a hiatal 
hernia. One hundred forty-eight patients had a type I 
hernia, 8 had type II, 9 had type III, and 4 had type IV. 
The surgical approach was through a left thoracotomy 
in 133 patients (71.9%), laparotomy in 27 (14.6%), and a 
thoracoabdominal incision in 25 (13.5%). Operative find- 
ings included a recurrent hernia in 116 patients (62.7%), 
a perigastric fundoplication in 22 (11.9%), a tight fundo- 
plication or hiatal closure in 21 (11.4%), a disrupted 
fundoplication in 19 (10.3%), or a combination of the 
previously listed findings in 7 (3.8%). A Nissen fundopli- 
cation was performed in 107 patients (57.8%), Belsey 
fundoplication in 47 (25.4%), truncal vagotomy and 
antrectomy with Roux-en-Y reconstruction i 17 (9.2%), 
anatomic hernia repair in 12 (6.5%), and Hill gastropexy 
in 2 (1.1%). An uncut Collis gastroplasty was added to the 
fundoplication in 85 patients; a cut Collis gastroplasty in
31; a pyloroplasty in 17; splenectomy in 2; excision of 
epiphrenic diverticulum in 2; and a truncal vagotomy, 
excision of gastric ulcer, and cricopharyngeal myotomy in 
one patient each. 
Results 
Complications occurred in 47 patients (25%) (Ta- 
ble I). There was one operative death (mortality 
0.5%). Cause of death was a leak and secondary 
sepsis after truncal vagotomy, antrectomy, and 
Roux-en-Y reconstruction. Median postoperative 
hospitalization was 9 days (range 5 to 58 days). All 
184 operative survivors were followed up for at least 
3 months. Fifteen patients (8.2%) needed esopha- 
geal dilatation within the first 3 months of reopera- 
tion. Functional results at 3 months were classified 
as excellent in 161 patients (87.0%), good in 13 
(7.0%), fair in 7 (3.8%), and poor in 3 (1.6%). 
Long-term follow-up was complete in 156 patients 
(84.3%) and ranged from 3 to 283 months (median 
31 months). Overall, 137 patients (87.8%) had im- 
proved conditions. Long-term functional results 
(Table I I)  were classified as excellent in 65 patients 
(41.6%), good in 29 (18.6%), fair in 43 (27.6%), and 
poor in 19 (12.2%). 
During follow-up, 20 patients (10.8%) required 
another operat ion for problems related to recurrent 
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or persistent GERD or gastric stasis a median of 28 
months after the antireflux procedure (range 0 to 
214 months). Esophageal resection was performed 
in 6 patients (3.3%), fundoplication in 5 (2.7%), 
pyloroplasty in 4 (2.2%), feeding jejunostomy in 4 
(2.2%), and antrectomy with Roux-en-Y reconstruc- 
tion in 1 (0.05%). Resection was for a nondilatable 
stricture in four patients and high-grade dysplasia in 
two with Barrett's disease. 
Overall analysis howed that preoperative factors 
including gender, age, symptoms, type or number of 
previous operations, preoperative dilatation, pres- 
ence of Barrett's disease, and endoscopy, manome- 
try, barium swallow, and pH findings did not affect 
late functional results. Likewise, the surgical ap- 
proach and type of reoperative procedure did not 
affect late functional results; however, the finding of 
a perigastric fundoplication at reoperation did cor- 
relate with a poor result (p < 0.05). AdditionallY, if 
early postoperative dilatation was required, this 
adversely affected the late functional result (p < 
0.05). Postoperative morbidity was not affected by 
the number of previous procedures (p = 0.08). 
Overall, estimated 5-, 10-, and 20-year freedom from 
another reoperation for recurrent or persistent 
GERD or related complications was 88.0% (95% 
confidence interval [CI], 81.3% to 94.5%), 86.3% 
(95% CI, 78.5% to 93.6%) and 69.1% (95% CI, 
50.0% to 87..7%), respectively (Fig. 1). 
Discussion 
Poor outcome after an antireflux procedure can 
result from a variety of causes. The most common is 
persistent or recurrent reflux resulting from an 
anatomic recurrence of a hiatal hernia, a perigastric 
fundoplication, an incompetent repair, or a partial 
or complete disruption of the repair. Late outcome 
is also dependent on a number of other variables 
including the functional and anatomic integrity of 
the stomach and esophagus, previous attempts at 
correction, and other associated conditions uch as 
chronic obstructive pulmonary disease or severe 
obesity. 19 Other complications 2°'21 which can con- 
tribute to a poor outcome include esophageal ob- 
struction, gastric stasis, dumping, severe gas-bloat 
syndrome, inability to belch or vomit, and diarrhea. 
The type and intensity of postoperative symptoms 
are variableY The majority of our patients (72.4%) 
had persistent or recurrent reflux symptoms. The 
remaining patients (27.6%) had esophageal obstruc- 
tion, and only one was without symptoms. The 
presence of dysphagia or other symptoms not clearly 
Table II. Long-term functional results in 156 
patients 
Symptoms Excellent Good Fair Poor 
None 65 - -  - -  - -  
Re f lux  - -  5 17 - -  
Dysphag ia  - -  20 21 15 
Gast r i c  stasis - -  - -  3 4 
Dumping  - -  4 2 - -  
Tota l  (%)  65 (41.6) 29 (18.6) 43 (27.6) 19 (12.2) 
caused by reflux suggests either a motility disorder 
or an obstructing lesion. The total number of pa- 
tients seen with symptoms after previous surgical 
treatment for GERD is unknown. At our institution 
the ratio of patients who had primary repair to those 
who had reoperatio n without resection was 11.2 to 1. 
The operative records of previous operations 
should be carefully reviewed19 when planning a 
reoperation. The approach, operative findings, dif- 
ficulties encountered, and the type of repair are 
essential information. Preoperative evaluation 
should also include barium upper gastrointestinal 
roentgenographic examination, esophagoscopy, 
esophageal motility, and pH monitoring. Barium 
swallow analysis is most useful to delineate gastri c
anatomy. Esophagoscopy allows histologic evalua- 
tion of the mucosa nd determination of whether a 
stricture is dilatable. Manometry can be difficult to 
interpret after a tight wrap and can mimic findings 
of achalasia or diffuse esophageal spasm. Neverthe- 
less, it helps decide whether a total or partial 
fundoplication should be performed, epending on 
the quality and amplitude Of esophageal peristalsis. 
If a question exists whether acid refux is present, 
pH monitoring can be of help. Symptoms suggesting 
delayed or accelerated gastric emptying should 
prompt a radionuclide gastric emPtying study. 
The choice of which procedure to perform can be 
difficult. Although no ideal operation exists, the goal 
of repair remains anatomic reduction of the hernia 
and a competent lower esophageal sphincter. The 
choice of reoperation should be individualized, 22
taking into consideration the state of the esophagus 
(stricture, motility disorder, fistula), th e presence of 
delayed gastric emptying, and previous repairs and 
approaches. Our preferred approach is by means of 
a thoracotomy when reoperating on patients with 
GERD. It allows optimal exposure of the thoracic 
portion of the esophagus and can be extended into 
the abdomen as a thoracoabdominalincision t  
improve exposure, particularly if a more extensive 
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Fig. 1. Actuarial cumulative probability of reoperation after the first reoperation for failed antireflux 
procedure. 
procedure is needed, such as an antrectomy with 
Roux-Y reconstruction or an esophageal resection. 
Alternatively, the diaphragm can be divided to 
facilitate xposure. The old repair should be taken 
down, and the integrity of the esophagus, esophago- 
gastric junction, and stomach should be assessed. In 
situations where extensive damage of the vagal 
fibers is suspected, a pyloroplasty should be added 
to the antireflux procedure. Deciding between a 
total or a partial fundoplication is more a question 
of personal choice when the propulsive characteris- 
tics of the esophagus are within normal limits. If 
peristalsis is of weak amplitude, however, a partial 
fundoplication should be performed. If the esopha- 
gus is short, a cut-Collis gastroplasty is done to 
provide an additional 2 to 3 cm of neoesophagus, 
which allows the repair to be placed under the 
diaphragm without tension. 23 The uncut-Collis gas- 
troplasty has been used in our experience to provide 
a secure anchor for the repair. 3' 24, 25 The crura 
should be approximated with heavy nonabsorbable 
sutures, and the repair should be reduced com- 
pletely under the diaphragm. 
Vagotomy and antrectomy with Roux-Y recon- 
struction was performed mostly as a tertiary proce- 
dure when the fundus was inadequate for any type 
of repair. Despite the potential disadvantage of 
regurgitation and aspiration of a bland refluxate, 1°it 
remains a viable alternative to extensive resec- 
tion.13, 26, 27 
Although not reviewed in this article, the question 
of when to resect is critical. In the report by Little 
and associates, 7 resection was more likely to be 
needed after multiple operations. In contrast, our 
data suggest hat late failure after reoperation was 
not a function of the number of previous repairs. 
Rather, failure in our patients occurred most com- 
monly because of obstruction rather than reflux 
(Table II), and the need for postoperative dilatation 
within 3 months of reoperation served as an early 
warning of late failure. This finding would suggest 
that, even after multiple repairs, patients hould be 
individualized, and we would favor resection only in 
patients with obstructive symptoms or when the 
quality of the tissue at the gastroesophageal junction 
is such that safe restoration of the lower esophageal 
sphincter is compromised. 2s Every effort should be 
made to retain the native esophagus when the 
process appears reversible. 
Functional results after reoperative antireflux sur- 
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Table IlL Other series 48' 10-13 
Author Year Patients Incision Repair Mortality Follow-up (YJ9 Results* 
Hill 1979 25 A Gastropexy 0 2 91% 
Henderson 1981 121 TA Othert 0 2.5 94% 
Leonardi 1981 25 A Various:~ 0 2.8 95% 
Little 1986 61 T, A Various$ 4.9% 3.8 42-85% 
Pearson 1987 118 T Other§ 0 - -  80% 
F6kdt6 1992 50 A Various 0 3.5 86% 
Skinner 1992 117 T, A Various$ 1.7% - -  - -  
Ellis 1994 36 T Other¶ 0 6.7 70% 
Stein 1996 71 - -  Various:~ 1.4% 3.5 86% 
Mayo 1996 185 T, TA, A Various 0.5% 3.7 60% 
A, Abdomina; TA, thoracoabdominal; T, 
*Excellent and good. 
+Total fundoplication, gastroplasty. 
.+Includes ophageal resection. 
§Partial fundoplication, gastroplasty. 
¶Vagotomy, antrectomy, Roux-en-Y. 
thoracic. 
gery deteriorate with time as shown by an increased 
rate of subsequent operations 20 years later as 
compared with only 5 years later. This increased late 
failure rate underlines the importance of adhering 
to strict principles of antireflux surgery at the initial 
operation. 
The use of laparoscopic techniques for treatment 
of GERD and hiatal hernia 29 should be viewed with 
great caution for reoperative hiatal hernia surgery. 3° 
Currently we do not recommend laparoscopy for 
redo hiatal hernia surgery. Only long-term evalua- 
tion will provide sufficient information regarding 
morbidity and functional results on which to base a 
judgment regarding this technique. 
Comparison with other similar series (Table III) 
is difficult given the heterogeneity of the different 
patient populations and the various operative tech- 
niques used. Equally as important ispersonal bias as 
surgeons often choose the procedures they are most 
comfortable with. 
In conclusion, reoperation with esophageal pres- 
ervation after a failed antireflux procedure will 
result in functional benefit in a majority of patients, 
but functional results deteriorate over time. A reop- 
eration can be done with low mortality and accept- 
able morbidity. Adherence to basic principles of 
antireflux surgery should be absolute, and the type 
of repair should be tailored to the individual patient. 
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Discuss ion 
Dr. Andre C. H. Duranceau (Montreal, Quebec, Cana- 
da). We must thank Dr. Deschamps and his associates for 
bringing to our attention a clear and concise summary of 
their results with a large series of patients reoperated for 
reflux disease. These patients are always difficult, they 
require patience, they require a meticulous technique. 
And, as expected, because the vast majority of those 
patients had a single operation before, a success rate of 
over 80% should be expected with a proper repair. 
I have one major preoccupation with your observation, 
which is based mostly on symptoms. Symptoms in gastro- 
esophageal disease are notoriously inaccurate, and they 
have been shown by Gibson when trying to correlate them 
with esophageal mucosal damage to result in a 22% error 
margin. And for that reason, it is difficult to accept 
symptoms either as an indication for surgery or as an 
estimation of its success. 
Today, when assessing esophageal damage from reflux 
disease, there are four objective measurements that are 
considered essential to confirm that an operation has been 
successful in its purpose-that is, to stop the reflux and 
allow present damage to either stabilize or regress. The 
addition of endoscopy, histology, reflux documentation by 
24-hour pH studies, and manometric recordings hould 
confirm and could confirm your impression that your 
excellent control of symptoms in 87% of patients at 3 
months and over time are indeed in correlation with the 
absence of reflux damage. 
Despite these remarks, this is an accurate and honest 
report on the immediate morbidity and mortality of 
reoperations. 
I have three questions. First, in the stage IV category of 
patients with a stricture and a columnar-lined sophagus, 
I would appreciate knowing what your results are in this 
subgroup, which represents 39% of your series, and if you 
came up with a higher incidence of complications and 
failures. Second, complications were seen in 25% of your 
group, and in 12 of these it was a fistula. Could you tell us 
whether this complication was seen more often with the 
creation of a gastroplasty, and, if so, their management 
and results? And finally, in the 25% of patients with no 
mucosal damage, those who are expected to have a major 
functional component to their symptoms, those with no 
mucosal damage before the operation, what were the 
indications for their operation and what were their results 
symptom-wise? Thank you. 
Dr. Desehamps. Dr. Duranceau, thank you for your 
kind comments. That is study spanning more than 30 
years. Indeed, not everybody had the test that would give 
you the extensive valuation of the disease, and we share 
your concern that you don't get the whole picture some- 
times when you don't do the proper test. Nowadays, in our 
experience, most of the patients, if not all of the patients, 
who are evaluated for possible surgery will get endoscopy 
and a barium swallow and a manometry, and we will get a 
pH only in selective patients. 
To answer your question about he results in stage IV, 
actually, in patients with advanced isease of Barrett's or 
stricture, the results were no different. We try hard to find 
factors associated with worst result or better esult, and 
we look at each category, including preoperative finding, 
and the result compared with the rest of the series. There 
were no more complications with the patient hat had 
Barrett's disease or stricture compared with the patient 
that had no damage on endoscopy. 
Of the 12 patients who had a leak, 6 of the 12 had an 
uncut Collis-Nissen; two had a Collis-Belsey; one had a 
Belsey; one, a patient who died, had an antrectomy, and 
she had a leak through the belly, underwent reoperation, 
and died because of sepsis and multiple organ failure; and 
two patients had an abdominal Nissen fundoplication. It 
seems that adding a gastroplasty might increase their risk 
in reoperation, but only half of our patients had an uncut 
Collis-Nissen. Of note, most of those leaks, 11 of 12, did 
not need reoperation and were treated conservatively with 
total parenteral nutrition and a longer hospital stay, and 
they all were healed without further intervention. 
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Of the patients who had no damage in their esophagus, 
the indication for surgery actually was aspiration and pain, 
most often caused by a paraesophageal recurrence. Those 
were the indications most of the time in patients with no 
damage in their esophagus. We do indeed at times 
operate on patients who have no damage, who have 
recurrent reflux and don't respond well to medical treat- 
ment even if they don't have damage. 
Dr. David B. Skinner (New York, N.Y.). That was a very 
nicely presented and fair assessment of a difficult problem. 
I guess the question in which I am interested is that, in the 
failures, you did some resections later, and I presume you 
excluded resections because this was a series of esopha- 
geal-preservation operations. Could you comment about 
your experience with resections? Your leak rate here of 
7% overall is about what you would expect in the resection 
series. 
Dr. Deschamps. Well, we are looking up our resection 
series, and I cannot give you the exact numbers, but it is 
possible that our morbidity will be higher and our leak 
rate will be higher as well. But I don't have the data on our 
resection for benign esophageal disease yet. 
